Designing the Future In Pharmaceuticals Trademark Details

Designing the Future in Pharmaceuticals was registered on Tuesday, February 17, 1998 and is currently owned by Genzyme Corporation under the registration number 2136551 . This mark is dead with a status of Cancelled - Section 8. The last case file activity for this mark occured 15 years ago on Friday, November 21, 2008, according to the United State Patent & Trademark Office
Word Mark Designing the Future in Pharmaceuticals
Status Dead Registered 710 — Cancelled - Section 8

Current Owner

Genzyme Corporation of Cambridge, MA

View all trademarks for Genzyme Corporation
Other Trademarks for Genzyme Corporation
Serial Number 75032818
Registration Number 2136551
Status Date Friday, November 21, 2008
Filing Date Friday, November 21, 2008
Registration Date Tuesday, February 17, 1998
Attorney William G. Gosz

Correspondent

Legal Department
Genzyme Corporation
15 Pleasant Street Connector
Framingham MA 01701-9322

Case File Statements

Goods & Services Developing Drugs and Intermediates for Others in the Pharmaceutical Industry

Classifications

International Class Codes
042 — Class 42 includes mainly services provided by persons, individually or collectively, in relation to the theoretical and practical aspects of complex fields of activities; such services are provided by members of professions such as chemists, physicists, engineers, computer programmers, etc.
U.S. Class Codes 100, 101
Status 2 — Sec. 8 – Entire Registration
Status Date Friday, November 21, 2008
First Use Anywhere Tuesday, September 19, 1995
First Use In Commerce Tuesday, September 19, 1995
Primary Code 042

You must be signed in to print.

Once signed in, look for the PDF button.